These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 29588532
1. Molecular changes preceding endometrial and ovarian cancer: a study of consecutive endometrial specimens from Lynch syndrome surveillance. Niskakoski A, Pasanen A, Lassus H, Renkonen-Sinisalo L, Kaur S, Mecklin JP, Bützow R, Peltomäki P. Mod Pathol; 2018 Aug; 31(8):1291-1301. PubMed ID: 29588532 [Abstract] [Full Text] [Related]
2. Converging endometrial and ovarian tumorigenesis in Lynch syndrome: Shared origin of synchronous carcinomas. Niskakoski A, Pasanen A, Porkka N, Eldfors S, Lassus H, Renkonen-Sinisalo L, Kaur S, Mecklin JP, Bützow R, Peltomäki P. Gynecol Oncol; 2018 Jul; 150(1):92-98. PubMed ID: 29716739 [Abstract] [Full Text] [Related]
3. Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia. Nieminen TT, Gylling A, Abdel-Rahman WM, Nuorva K, Aarnio M, Renkonen-Sinisalo L, Järvinen HJ, Mecklin JP, Bützow R, Peltomäki P. Clin Cancer Res; 2009 Sep 15; 15(18):5772-83. PubMed ID: 19723644 [Abstract] [Full Text] [Related]
4. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation. Niskakoski A, Kaur S, Staff S, Renkonen-Sinisalo L, Lassus H, Järvinen HJ, Mecklin JP, Bützow R, Peltomäki P. Epigenetics; 2014 Dec 15; 9(12):1577-87. PubMed ID: 25625843 [Abstract] [Full Text] [Related]
5. Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas. Rambau PF, Duggan MA, Ghatage P, Warfa K, Steed H, Perrier R, Kelemen LE, Köbel M. Histopathology; 2016 Aug 15; 69(2):288-97. PubMed ID: 26799366 [Abstract] [Full Text] [Related]
6. Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers. Kim SR, Tone A, Kim R, Cesari M, Clarke B, Eiriksson L, Hart T, Aronson M, Holter S, Lytwyn A, Maganti M, Oldfield L, Gallinger S, Bernardini MQ, Oza AM, Djordjevic B, Lerner-Ellis J, Van de Laar E, Vicus D, Pugh TJ, Pollett A, Ferguson SE. Int J Gynecol Cancer; 2020 Dec 15; 30(12):1951-1958. PubMed ID: 33082239 [Abstract] [Full Text] [Related]
7. Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomas. Niskakoski A, Kaur S, Renkonen-Sinisalo L, Lassus H, Järvinen HJ, Mecklin JP, Bützow R, Peltomäki P. Int J Cancer; 2013 Dec 01; 133(11):2596-608. PubMed ID: 23716351 [Abstract] [Full Text] [Related]
8. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies. Ryan NAJ, Morris J, Green K, Lalloo F, Woodward ER, Hill J, Crosbie EJ, Evans DG. JAMA Oncol; 2017 Dec 01; 3(12):1702-1706. PubMed ID: 28772289 [Abstract] [Full Text] [Related]
12. Frequent loss of mutation-specific mismatch repair protein expression in nonneoplastic endometrium of Lynch syndrome patients. Wong S, Hui P, Buza N. Mod Pathol; 2020 Jun 01; 33(6):1172-1181. PubMed ID: 31932681 [Abstract] [Full Text] [Related]